DEFINED BENEFIT PLAN

9 Months Ended

Jun. 30, 2023

8. DEFINED BENEFIT PLAN

The Company has a defined benefit plan in the U.K., the Harlan Laboratories UK Limited Occupational Pension Scheme (the "Pension Plan"), which operated through April 2012. As of April 30, 2012, the accumulation of plan benefits of employees in the Pension Plan was permanently suspended and therefore the Pension Plan was curtailed. During the year ending September 30, 2023, the Company expects to contribute $1,266 to the Pension Plan. As of June 30, 2023, the funded status of the defined benefit plan obligation of $3,019 is included in other assets (non-current) in the condensed consolidated balance sheets.

The following table provides the components of net periodic benefit costs for the Pension Plan, which is included in general and administrative expenses in the condensed consolidated statements of operations.


	Three Months Ended June 30,				Nine Months Ended June 30,
	2023		2022		2023		2022
Components of net periodic (benefit) expense:
Interest cost	$	187	$	207	$	551	$	344
Expected return on assets	(203)		(352)		(600)		(681)
Amortization of prior (gain) loss	(39)		177		(114)		454
Net periodic (benefit) expense	$	(55)	$	32	$	(163)	$	117